Know which analysts are right to invest in? Glenmark Life Science IPO or Rolex Rings Which one is better as per analysts

Initial Public Offerings (IPOs) of two companies are open for subscription in the stock market. The IPO of Glenmark Life Sciences, a subsidiary of Glenmark Pharma, is open from July 27 to Thursday (July 29) with a price band of Rs 695-720 per share. The company wants to raise around Rs 1,514 crore through this.

Glenmark Life Sciences’ public offering was subscribed nearly 6.5 times till Thursday morning. There is a lot of interest from retail investors in this.

Automotive components manufacturer Rolex Rings’ public offer opened on July 28 and will close on July 30. Till Thursday morning, the company had got more than 5 times subscription for it.

Co-lending agreement between Yes Bank and Indiabulls, with this deal customers will get cheaper home loans

gray market premium

The shares of Glenmark Life Sciences are trading at a premium of Rs 150 in the gray market. This means a trading price of Rs 870 per share.

Shares of Rolex Rings are trading at a premium of Rs 450-460 per share in the gray market. This means a trading price of Rs 1,350-1,360. This is almost 50 per cent more than the issue price of Rs 900.

Though the two companies belong to different sectors, analysts are increasingly interested in Glenmark as it holds a significant stake in active pharmaceutical ingredients businesses.

Ashish Chaturmohta, Research Director, Sanctum Wealth Management, said, “Both companies are from different sectors. Rolex Ring is associated with the automobile sector and Glenmark is in CDMO with Life Sciences Pharma. I believe that Glenmark is valued because of its strong core company. Must subscribe. It has good growth potential in the long term.”

Facebook us for social media updates ( and Twitter ( to follow.

For More News Visit DD Direct News